NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NA
Post# of 326
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that its CEO John Climaco will present at the Q2 Virtual Investor Summit at 12:30 p.m. ET on Tuesday, May 18. In addition to the presentation, CNS management will be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. Interested parties should visit https://nnw.fm/KZgoi for more information and to register for the conference. A video webcast will be accessible on the company’s website and will be archived for 90 days following the event.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer